Essential tremor into tremulous Parkinson’s disease or they are two separate diseases?
Keywords:
Essential tremor, Parkinson’s disease, co-morbidityAbstract
There is contradictory information in the global literature regarding patients diagnosed with Essential tremor (ET) and their ability to obtain Parkinson’s disease (PD) afterwards. It is difficult to say if there is co-morbidity between the two diseases or they are two separate nosologies. The second question is if the ET has outgrown into PD due to a higher risk for neurodegeneration in patients with ET. It is necessary clinical trials, prolonged observation of patients and performance of additional specialized examinations to be conducted. It is also important specific pathophysiological, genetic and lab tests to be developed and used. The correct recognition of the two diseases leads to an adequate treatment, prevention of the fast progression of the disease and provides a better quality of life for the patients and their relatives.
References
Bogdanova, D., Milanov, I. Esentsialen tremor i Parkinsonova bolest – pregled na literaturata i prosledyavane na 114 bolnitsi. Dvigatelni narusheniya, 2004, 1, 2, 36-42.
Georgiev, D., Milanov, I., Chipilski, L. Aktualni problemi pri nyakoi ekstrapiramidni zabolyavaniya. Sofiya : “AS” OOD, 1996, 143 str.
Milanov, I. Sŭvremenni razbiraniya za patogeneza na Parkinsonovata bolest. Dvigatelni narusheniya, 2014, 11, 2, 13-22.
Milanov, I. Uchebnik po nevrologiya, Meditsina i fizkultura, 2012, 1056 str.
Cheshire, P., Pfeiffer, F. Is α-synuclein rising to the surface as a diagnostic biomarker for Parkinson disease? Neurology, 2013, 81, 18, 1568-1579.
Abraham, A., Drory, V., Influence of serum uric acid levels on prognosis and survival in amyotrophic lateral sclerosis: a meta-analysis, J. Neurol, 2014, 261,1133-1138.
Algarni, M., Fasano, A. The overlap between Essential tremor and Parkinson disease, Parkinsonism Relat Disord. 46, 2018, S101eS104.
Antonini, A. Continuous dopaminergic stimulation – from theory to clinical practice. Parkinsonism Relat. Disord., 2007, 13 Suppl., 24-28.
Barbosa, R., Mendonca, M., Ladeira, F., Miguel, R., Bugalho, P. Probable REM-sleep behavior disorder and dysautonomic symptoms in essential tremor. Tremor Other Hyperkinet Mov, 2017, 7.
Brooks, D. Dopamine agonists: their role in the treatment of Parkinson's disease. Journal of Neurology, Neurosurgery and Psychiatry, 2000, 68, 685-689.
Central Spain Study Group. Risk of incident Parkinson’s disease and parkinsonism in essential tremor: a population based study. J Neurol Neurosurg Psychiatry. 2008, 80, 423-425.
Chen, H., Yuan, L., Song, Z., Deng, X., Yang, Y, Gong, L., Zi, X., Deng, H. Genetic analysis of LRRK1 and LRRK2 variants in essential tremor patients, Genet Test Mol Biomarkers. 22, 6, 2018, 398-402.
Geraghty, J., Jankovic, J., Zetusky, W. Association between essential tremor and Parkinson’s disease. Ann Neurol. 1985, 17, 329-333.
Gerasimou, G., Costa, D., Papanastasiou, E., Bostanjiopoulou, S., Arnaoutoglou, M., Moralidis, E. SPECT study with I-123-Ioflupane (DaTSCAN) in patients with essential tremor. Is there any correlation with Parkinson’s disease? Ann Nucl Med. 2012, 26, 337-344.
Hopfner, F., Deuschl, G. Is essential tremor a single entity? Eur. J. Neurol. 2018, 25, 1, 71-82.
Jimenez-Shahed, J., Diamond, A., Vuong, K., Jankovic, J. Characteristics of Parkinson’s disease in patients with childhood-onset essential tremor. Mov Disord. 2005, 20, S169.
Jin, L., Wang, J., Wang, C., Lian, D. Combined visualization of nigrosome-1 and neuromelanin in the substantia nigra using 3T MRI for the differential diagnosis of essential tremor and de novo Parkinson’s disease, Front. Neurol. 2019, 10, 100.
Lee, C., Yoon, J., Park, J., Hong, J., Sunwoo, M. Uric acid level may not be reduced in essential tremor, Int J Neurosci. 2018, 128, 12, 1163-1167.
Lou, J., Jankovic, J. Essential tremor: clinical correlates in 350 patients. Neurology, 1991, 41, 234-238.
Louis, E. Chapter 16: essential tremor and the cerebellum, Handbook Clinical Neurol. 155 (3rd series). 2018, 245-258.
Louis, E., Faust, P., Vonsattel, J., Honig, L. Torpedoes in Parkinson’s disease, Alzheimer’s disease, essential tremor and control brains. Mov Disord. 2009, 24, 1600-1605.
Louis, E., Faust, P., Vonsattel, J., Honig, L. Neuropathological changes in essential tremor: 33 cases compared with 21 controls. Brain. 2007, 130, 3297-3307.
Lu M-K, Chen C-M, Duann J-R, Ziemann U, Chen J-C, Chiou S-M. Investigation of motor cortical plasticity and corticospinal tract diffusion tensor imaging in patients with Parkinsons disease and essential tremor. PLoS-One, 2016, 11.
Muthuraman, M., Raethjen, J., Koirala, N. Cerebello-cortical network fingerprints differ between essential, Parkinson’s and mimicked tremors. Brain 2018, 141,1770-1781.
Shill, H., Adler, C., Sabbagh, M., Connor, D., Caviness, J., Hentz, J. Pathologic findings in prospectively ascertained essential tremor subjects. Neurology 2008, 70, 1452-1455.
Stefansson, H., Steinberg, S., Petursson, H., Gustafsson, O., Gudjonsdottir, I., Jonsdottir, G. Variant in the sequence of the LINGO1 gene confers risk of essential tremor. Nat Genet, 2009, 41, 277-279.
Tarakad, A., Jankovic, J. Essential tremor and Parkinson’s disease: exploring the relationship, Tremor Other Hyperkinet Mov. 2019, 8, 589.
Vilarin˜o-Gu, C., Wider, C., Ross, O., Jasinska-Myga, B., Kachergus, J., Cobb, S. LINGO1 and LINGO2 variants are associated with essential tremor and Parkinson disease. Neurogenetics. 2010, 11, 401-408.
Wu, T., Hallett, M. The cerebellum in Parkinson’s disease. Brain. 2013, 136, 696-709.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2020 Elena Chorbadjieva, I. Milanov, D. Georgiev
This work is licensed under a Creative Commons Attribution 4.0 International License.
